Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Am J Med. 2014 Mar 13;127(8):754–762. doi: 10.1016/j.amjmed.2014.03.002

Table 3.

Medications received: Biochemically adrenal-cortisol insufficient vs. sufficient inpatients *

Biochemically adrenal- cortisol insufficient n=108 Biochemically adrenal- cortisol sufficient n=394 p value
Anti-infectious 62.0 (67) 46.8 (184) 0.005
Pulmonary 29.6 (32) 18.5 (73) 0.01
Cardiovascular 53.7 (58) 60.7 (239) 0.19
Diuretics 12.0 (13) 18 (71) 0.14
Neuro- modulators 66.7 (72) 58.4 (230) 0.12
Hematologic 48.1 (52) 44.4 (175) 0.49
Endocrine 40.7 (44) 43.7 (172) 0.59
Chemotherapy & radiation 13.0 (14) 12.9 (51) >0.99
Gastrointestinal 65.7 (71) 65.2 (257) 0.92
Skeletal 7.4 (8) 10.9 (43) 0.37
Megestrol 15.7 (17) 8.4 (33) 0.02
Azole antifungals 11.1 (12) 6.3 (25) 0.10
Mitotane/metyrapone 0 0.3 (1)
Etomidate 0.9 (1) 0
Prior glucocorticoids 7.4 (8) 9.1 (36) 0.70
Prior fludrocortisone 2.8 (3) 1.8 (7) 0.45
*

presented as % (n)

Anti-fungal azole drugs including ketoconazole, fludroconazole and voriconazole

Patients who received glucocorticoids at doses equivalent to ≥ 30 mg daily hydrocortisone for ≥ 2 weeks up to 24 hours prior to cortrosyn injection.